Articles

Results 1 to 5 of 6


Senate passes drug pricing legislation

USA - August 8 2022 On August 7, 2022, the Senate passed the proposed Inflation Reduction Act of 2022, which includes a number of significant drug pricing-related…

Alice Valder Curran, Melissa K. Bianchi, Mahmud Brifkani, Ken Choe, Elizabeth (Beth) Halpern, Ashley Ifeadike, Stuart M. Langbein, Samantha D. Marshall, Kathleen A. Peterson, Beth L. Roberts, Cybil Roehrenbeck

U.S. House passes drug pricing legislation

USA - November 19 2021 This morning, the U.S. House passed drug pricing legislation as part of the Build Back Better Act (BBBA) (specifically the Rules Committee version…

Alice Valder Curran, Melissa K. Bianchi, Ken Choe, Elizabeth (Beth) Halpern, Stuart M. Langbein, Samantha D. Marshall, Kathleen A. Peterson, Beth L. Roberts, Cybil Roehrenbeck, Ron Wisor

Ramping up the drug pricing debate: Dueling bills and paying for health care infrastructure

USA - April 26 2021 The U.S. House of Representatives is considering dueling proposals related to drug pricing under Medicaid and Medicare, including the Republican-led H…

Alice Valder Curran, Thomas Beimers, Melissa K. Bianchi, Mahmud Brifkani, Ken Choe, James M. Deal, Elizabeth (Beth) Halpern, James Huang, W. Boyd Jackson, Stuart M. Langbein, Samantha D. Marshall, Beth L. Roberts, Cybil Roehrenbeck, Ron Wisor

Congress passes, and the President signs, a sweeping $1.9 trillion COVID-19 relief package

USA - March 11 2021 In his first significant legislative achievement in office, President Biden quickly signed the American Rescue Plan, legislation passed by Congress…

Shelley Castle

No Surprises Act prohibits balance billing, creates arbitration process for out-of-network providers

USA - February 16 2021 Effective January 1, 2022, the “No Surprises Act” signed into U.S. law as part of H.R. 133, “Consolidated Appropriations Act, 2021,” implicates (1)…

Ken Choe, Beth L. Roberts, Victoria M. Wallace, Ron Wisor